- CH₣246.94bn
- CH₣272.31bn
- CH₣60.50bn
- 96
- 29
- 93
- 89
Annual balance sheet for Roche Holding AG, fiscal year end - December 31st, CHF millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 12,334 | 13,031 | 9,767 | 10,510 | 17,317 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 11,740 | 12,651 | 13,866 | 12,980 | 13,485 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 32,942 | 35,627 | 33,816 | 33,446 | 40,036 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 23,270 | 24,412 | 24,208 | 22,939 | 23,740 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 86,138 | 92,317 | 88,151 | 90,468 | 101,801 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 25,401 | 38,416 | 27,239 | 24,824 | 27,023 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 49,797 | 67,828 | 60,159 | 61,153 | 70,034 |
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Unrealized Gain / Loss | |||||
| Other Equity | |||||
| Total Equity | 36,341 | 24,489 | 27,992 | 29,315 | 31,767 |
| Total Liabilities & Shareholders' Equity | 86,138 | 92,317 | 88,151 | 90,468 | 101,801 |
| Total Common Shares Outstanding |